Norepinephrine bitartrate and Spironolactone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Norepinephrine bitartrate (norepinephrine bitartrate) and Spironolactone (spironolactone). Common drug interactions include oxygen saturation decreased among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Norepinephrine bitartrate and Spironolactone. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Norepinephrine bitartrate?

Norepinephrine bitartrate has active ingredients of norepinephrine bitartrate. eHealthMe is studying from 2,370 Norepinephrine bitartrate users. Check the latest studies of Norepinephrine bitartrate.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.



On Jul, 08, 2026

60 people who take Norepinephrine bitartrate and Spironolactone together, and have interactions are studied.

Norepinephrine bitartrate and Spironolactone drug interactions.

What are the common drug interactions of Norepinephrine Bitartrate and Spironolactone, by gender? *:

female:

  1. Oxygen saturation decreased
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Septic shock (shock due to blood infection)
  4. Bradycardia (abnormally slow heart action)
  5. Burkholderia test positive
  6. Cough
  7. Dyspnoea (difficult or laboured respiration)
  8. Loss of consciousness
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Neutropenic infection (infection with less neutrophil numbers in blood)

male:

  1. Pneumonia
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  4. Cardiac output decreased
  5. Cardiogenic shock (inadequate circulation of blood)
  6. Cerebellar ischaemia (lack of blood supply to cerebeller)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Encephalopathy (functioning of the brain is affected by some agent or condition)
  9. Haematoma (collection of blood outside the blood vessels)
  10. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)

What are the common drug interactions of Norepinephrine Bitartrate and Spironolactone, by age (0-1 to 60+)? *:

0-1:

  1. Drug ineffective

2-9:

  1. Bradycardia (abnormally slow heart action)
  2. Oxygen saturation decreased
  3. Respiratory failure (excl neonatal) (inadequate gas exchange by the respiratory system(excluding neonatal))
  4. Sepsis (a severe blood infection that can lead to organ failure and death)

10-19:

n/a

20-29:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Chest pain
  4. Diarrhoea
  5. Headache (pain in head)
  6. Liver disorder (liver diseases)
  7. Oxygen saturation decreased
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Platelet count decreased
  10. Pulmonary oedema (fluid accumulation in the lungs)

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Death
  4. Emotional distress
  5. Fear
  6. Injury
  7. Multi-organ failure (multisystem organ failure)
  8. Pain
  9. Renal failure (kidney dysfunction)
  10. Renal impairment (severely reduced kidney function)

50-59:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  7. Hepatic failure (liver failure)
  8. Liver disorder (liver diseases)
  9. Pneumonia
  10. Pulmonary hypertension (increase in blood pressure in the lung artery)

60+:

  1. Pneumonia
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Macule (a discoloured spot on the skin)
  4. Radiation pneumonitis (inflammation of lung due to radiation)
  5. Renal injury (kidney injury)
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Emotional distress
  9. Loss of consciousness
  10. Multi-organ failure (multisystem organ failure)

What are the existing conditions these people have? *

  1. Hypotension (abnormally low blood pressure): 11 people, 18.33%
  2. High Blood Pressure: 9 people, 15.00%
  3. Sedation: 8 people, 13.33%
  4. Pain: 8 people, 13.33%
  5. Urination - Excessive Volume: 7 people, 11.67%
  6. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 10.00%
  7. Local Anaesthesia: 5 people, 8.33%
  8. Asthma: 5 people, 8.33%
  9. Haemorrhage (bleeding): 4 people, 6.67%
  10. Enlarged Prostate: 4 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Norepinephrine bitartrate and Spironolactone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Norepinephrine bitartrate and Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Norepinephrine bitartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Norepinephrine bitartrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spironolactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on norepinephrine bitartrate and spironolactone (the active ingredients of Norepinephrine bitartrate and Spironolactone, respectively), and Norepinephrine bitartrate and Spironolactone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: